nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Hepatocellular carcinoma—Entecavir—hepatitis B	0.0577	0.0722	CcSEcCtD
Cyproterone acetate—Hepatic cirrhosis—Entecavir—hepatitis B	0.055	0.0688	CcSEcCtD
Cyproterone acetate—Hepatic cancer—Entecavir—hepatitis B	0.0525	0.0657	CcSEcCtD
Cyproterone acetate—CYP19A1—semen—hepatitis B	0.0494	0.368	CbGeAlD
Cyproterone acetate—AR—semen—hepatitis B	0.0437	0.326	CbGeAlD
Cyproterone acetate—Ascites—Entecavir—hepatitis B	0.0232	0.029	CcSEcCtD
Cyproterone acetate—Hypertrophy of breast—Lamivudine—hepatitis B	0.0207	0.0259	CcSEcCtD
Cyproterone acetate—Hepatomegaly—Entecavir—hepatitis B	0.0149	0.0186	CcSEcCtD
Cyproterone acetate—Hepatomegaly—Telbivudine—hepatitis B	0.0122	0.0153	CcSEcCtD
Cyproterone acetate—NR3C1—blood plasma—hepatitis B	0.0115	0.0859	CbGeAlD
Cyproterone acetate—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0112	0.0141	CcSEcCtD
Cyproterone acetate—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0108	0.0135	CcSEcCtD
Cyproterone acetate—Tenderness—Telbivudine—hepatitis B	0.00993	0.0124	CcSEcCtD
Cyproterone acetate—Hepatic failure—Entecavir—hepatitis B	0.00852	0.0107	CcSEcCtD
Cyproterone acetate—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00831	0.0104	CcSEcCtD
Cyproterone acetate—Breast enlargement—Lamivudine—hepatitis B	0.00752	0.00941	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Entecavir—hepatitis B	0.00717	0.00897	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00699	0.00875	CcSEcCtD
Cyproterone acetate—Hepatomegaly—Lamivudine—hepatitis B	0.0069	0.00862	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00689	0.00862	CcSEcCtD
Cyproterone acetate—CYP19A1—blood—hepatitis B	0.00659	0.0491	CbGeAlD
Cyproterone acetate—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00659	0.00824	CcSEcCtD
Cyproterone acetate—Pancreatitis—Entecavir—hepatitis B	0.00648	0.00811	CcSEcCtD
Cyproterone acetate—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00633	0.00791	CcSEcCtD
Cyproterone acetate—Migraine—Telbivudine—hepatitis B	0.00619	0.00774	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Entecavir—hepatitis B	0.00597	0.00746	CcSEcCtD
Cyproterone acetate—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00584	0.0073	CcSEcCtD
Cyproterone acetate—AR—blood—hepatitis B	0.00584	0.0435	CbGeAlD
Cyproterone acetate—Acne—Lamivudine—hepatitis B	0.0058	0.00725	CcSEcCtD
Cyproterone acetate—Renal failure—Entecavir—hepatitis B	0.0058	0.00725	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00566	0.00708	CcSEcCtD
Cyproterone acetate—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00566	0.00707	CcSEcCtD
Cyproterone acetate—Haematuria—Entecavir—hepatitis B	0.00562	0.00703	CcSEcCtD
Cyproterone acetate—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00561	0.00701	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Entecavir—hepatitis B	0.00558	0.00698	CcSEcCtD
Cyproterone acetate—Muscular weakness—Telbivudine—hepatitis B	0.00554	0.00693	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00554	0.00693	CcSEcCtD
Cyproterone acetate—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00549	0.00686	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00544	0.00681	CcSEcCtD
Cyproterone acetate—Hepatitis—Entecavir—hepatitis B	0.00529	0.00662	CcSEcCtD
Cyproterone acetate—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00517	0.00646	CcSEcCtD
Cyproterone acetate—CYP19A1—liver—hepatitis B	0.00515	0.0384	CbGeAlD
Cyproterone acetate—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00508	0.00635	CcSEcCtD
Cyproterone acetate—Immune system disorder—Entecavir—hepatitis B	0.00478	0.00598	CcSEcCtD
Cyproterone acetate—Renal failure—Telbivudine—hepatitis B	0.00476	0.00596	CcSEcCtD
Cyproterone acetate—Alopecia—Entecavir—hepatitis B	0.00468	0.00585	CcSEcCtD
Cyproterone acetate—Mental disorder—Entecavir—hepatitis B	0.00464	0.0058	CcSEcCtD
Cyproterone acetate—Malnutrition—Entecavir—hepatitis B	0.00461	0.00576	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Telbivudine—hepatitis B	0.00458	0.00573	CcSEcCtD
Cyproterone acetate—AR—liver—hepatitis B	0.00456	0.034	CbGeAlD
Cyproterone acetate—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.0045	0.00562	CcSEcCtD
Cyproterone acetate—Gynaecomastia—Lamivudine—hepatitis B	0.00437	0.00546	CcSEcCtD
Cyproterone acetate—Hepatitis—Telbivudine—hepatitis B	0.00435	0.00544	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Telbivudine—hepatitis B	0.00427	0.00535	CcSEcCtD
Cyproterone acetate—NR3C1—blood—hepatitis B	0.00423	0.0315	CbGeAlD
Cyproterone acetate—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00416	0.0052	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—AKR1B1—hepatitis B	0.00414	0.0626	CbGpPWpGaD
Cyproterone acetate—Leukopenia—Entecavir—hepatitis B	0.00413	0.00516	CcSEcCtD
Cyproterone acetate—Phlebitis—Lamivudine—hepatitis B	0.00411	0.00514	CcSEcCtD
Cyproterone acetate—Sleep disorder—Lamivudine—hepatitis B	0.00409	0.00512	CcSEcCtD
Cyproterone acetate—Cough—Adefovir Dipivoxil—hepatitis B	0.00392	0.00491	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Telbivudine—hepatitis B	0.00392	0.0049	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.0039	0.00487	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0038	0.00475	CcSEcCtD
Cyproterone acetate—Malnutrition—Telbivudine—hepatitis B	0.00379	0.00474	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Entecavir—hepatitis B	0.00369	0.00461	CcSEcCtD
Cyproterone acetate—Skin disorder—Entecavir—hepatitis B	0.00365	0.00457	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0036	0.0045	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00359	0.00449	CcSEcCtD
Cyproterone acetate—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00356	0.00446	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Telbivudine—hepatitis B	0.00351	0.00439	CcSEcCtD
Cyproterone acetate—Anorexia—Adefovir Dipivoxil—hepatitis B	0.0035	0.00438	CcSEcCtD
Cyproterone acetate—Migraine—Lamivudine—hepatitis B	0.00349	0.00436	CcSEcCtD
Cyproterone acetate—Affect lability—Lamivudine—hepatitis B	0.00349	0.00436	CcSEcCtD
Cyproterone acetate—Malaise—Telbivudine—hepatitis B	0.00341	0.00427	CcSEcCtD
Cyproterone acetate—Mood swings—Lamivudine—hepatitis B	0.00336	0.0042	CcSEcCtD
Cyproterone acetate—Dyspepsia—Entecavir—hepatitis B	0.00331	0.00414	CcSEcCtD
Cyproterone acetate—NR3C1—liver—hepatitis B	0.00331	0.0246	CbGeAlD
Cyproterone acetate—Cough—Telbivudine—hepatitis B	0.0033	0.00413	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Lamivudine—hepatitis B	0.00327	0.00409	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Entecavir—hepatitis B	0.00325	0.00406	CcSEcCtD
Cyproterone acetate—Fatigue—Entecavir—hepatitis B	0.00324	0.00406	CcSEcCtD
Cyproterone acetate—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00323	0.00404	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0032	0.004	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00319	0.00399	CcSEcCtD
Cyproterone acetate—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00319	0.00399	CcSEcCtD
Cyproterone acetate—Discomfort—Telbivudine—hepatitis B	0.00318	0.00398	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00317	0.00396	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00312	0.00391	CcSEcCtD
Cyproterone acetate—Muscular weakness—Lamivudine—hepatitis B	0.00312	0.00391	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Entecavir—hepatitis B	0.00308	0.00385	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Telbivudine—hepatitis B	0.00303	0.00379	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00303	0.0458	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Telbivudine—hepatitis B	0.00303	0.00378	CcSEcCtD
Cyproterone acetate—Pancreatitis—Lamivudine—hepatitis B	0.003	0.00375	CcSEcCtD
Cyproterone acetate—Skin disorder—Telbivudine—hepatitis B	0.003	0.00375	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.003	0.00375	CcSEcCtD
Cyproterone acetate—Sweating increased—Lamivudine—hepatitis B	0.00298	0.00373	CcSEcCtD
Cyproterone acetate—Body temperature increased—Entecavir—hepatitis B	0.00297	0.00372	CcSEcCtD
Cyproterone acetate—Abdominal pain—Entecavir—hepatitis B	0.00297	0.00372	CcSEcCtD
Cyproterone acetate—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.0029	0.00363	CcSEcCtD
Cyproterone acetate—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.0029	0.00363	CcSEcCtD
Cyproterone acetate—Pollakiuria—Lamivudine—hepatitis B	0.00283	0.00354	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Lamivudine—hepatitis B	0.00276	0.00345	CcSEcCtD
Cyproterone acetate—Dyspepsia—Telbivudine—hepatitis B	0.00272	0.0034	CcSEcCtD
Cyproterone acetate—Asthenia—Entecavir—hepatitis B	0.0027	0.00338	CcSEcCtD
Cyproterone acetate—Renal failure—Lamivudine—hepatitis B	0.00268	0.00336	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00267	0.00334	CcSEcCtD
Cyproterone acetate—Fatigue—Telbivudine—hepatitis B	0.00266	0.00333	CcSEcCtD
Cyproterone acetate—Jaundice—Lamivudine—hepatitis B	0.00266	0.00333	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptors—HNF4A—hepatitis B	0.00266	0.0401	CbGpPWpGaD
Cyproterone acetate—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00263	0.00329	CcSEcCtD
Cyproterone acetate—Sweating—Lamivudine—hepatitis B	0.00262	0.00327	CcSEcCtD
Cyproterone acetate—Pruritus—Adefovir Dipivoxil—hepatitis B	0.0026	0.00325	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Lamivudine—hepatitis B	0.00258	0.00323	CcSEcCtD
Cyproterone acetate—Diarrhoea—Entecavir—hepatitis B	0.00257	0.00322	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Telbivudine—hepatitis B	0.00255	0.00318	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Telbivudine—hepatitis B	0.00253	0.00316	CcSEcCtD
Cyproterone acetate—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00251	0.00314	CcSEcCtD
Cyproterone acetate—Dizziness—Entecavir—hepatitis B	0.00249	0.00311	CcSEcCtD
Cyproterone acetate—Hepatitis—Lamivudine—hepatitis B	0.00245	0.00307	CcSEcCtD
Cyproterone acetate—Abdominal pain—Telbivudine—hepatitis B	0.00244	0.00305	CcSEcCtD
Cyproterone acetate—Body temperature increased—Telbivudine—hepatitis B	0.00244	0.00305	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Lamivudine—hepatitis B	0.00241	0.00301	CcSEcCtD
Cyproterone acetate—Vomiting—Entecavir—hepatitis B	0.00239	0.00299	CcSEcCtD
Cyproterone acetate—Rash—Entecavir—hepatitis B	0.00237	0.00297	CcSEcCtD
Cyproterone acetate—Dermatitis—Entecavir—hepatitis B	0.00237	0.00296	CcSEcCtD
Cyproterone acetate—Headache—Entecavir—hepatitis B	0.00236	0.00295	CcSEcCtD
Cyproterone acetate—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00233	0.00292	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Lamivudine—hepatitis B	0.00232	0.0029	CcSEcCtD
Cyproterone acetate—Rash—Adefovir Dipivoxil—hepatitis B	0.00231	0.00289	CcSEcCtD
Cyproterone acetate—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00231	0.00289	CcSEcCtD
Cyproterone acetate—Headache—Adefovir Dipivoxil—hepatitis B	0.0023	0.00288	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.0023	0.0347	CbGpPWpGaD
Cyproterone acetate—Nausea—Entecavir—hepatitis B	0.00223	0.00279	CcSEcCtD
Cyproterone acetate—Asthenia—Telbivudine—hepatitis B	0.00222	0.00277	CcSEcCtD
Cyproterone acetate—Immune system disorder—Lamivudine—hepatitis B	0.00221	0.00277	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Lamivudine—hepatitis B	0.00221	0.00276	CcSEcCtD
Cyproterone acetate—Chills—Lamivudine—hepatitis B	0.0022	0.00275	CcSEcCtD
Cyproterone acetate—Pruritus—Telbivudine—hepatitis B	0.00219	0.00273	CcSEcCtD
Cyproterone acetate—Nausea—Adefovir Dipivoxil—hepatitis B	0.00218	0.00273	CcSEcCtD
Cyproterone acetate—Alopecia—Lamivudine—hepatitis B	0.00217	0.00271	CcSEcCtD
Cyproterone acetate—Malnutrition—Lamivudine—hepatitis B	0.00213	0.00267	CcSEcCtD
Cyproterone acetate—Diarrhoea—Telbivudine—hepatitis B	0.00211	0.00264	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.0021	0.0317	CbGpPWpGaD
Cyproterone acetate—Tension—Lamivudine—hepatitis B	0.00209	0.00262	CcSEcCtD
Cyproterone acetate—Dizziness—Telbivudine—hepatitis B	0.00204	0.00256	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptors—HNF4A—hepatitis B	0.00202	0.0305	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Lamivudine—hepatitis B	0.00198	0.00248	CcSEcCtD
Cyproterone acetate—Anaemia—Lamivudine—hepatitis B	0.00197	0.00247	CcSEcCtD
Cyproterone acetate—Vomiting—Telbivudine—hepatitis B	0.00196	0.00246	CcSEcCtD
Cyproterone acetate—Rash—Telbivudine—hepatitis B	0.00195	0.00244	CcSEcCtD
Cyproterone acetate—Dermatitis—Telbivudine—hepatitis B	0.00195	0.00243	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—NR0B2—hepatitis B	0.00194	0.0293	CbGpPWpGaD
Cyproterone acetate—Headache—Telbivudine—hepatitis B	0.00194	0.00242	CcSEcCtD
Cyproterone acetate—Malaise—Lamivudine—hepatitis B	0.00192	0.00241	CcSEcCtD
Cyproterone acetate—Syncope—Lamivudine—hepatitis B	0.00191	0.00239	CcSEcCtD
Cyproterone acetate—Leukopenia—Lamivudine—hepatitis B	0.00191	0.00239	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Lamivudine—hepatitis B	0.00188	0.00235	CcSEcCtD
Cyproterone acetate—Cough—Lamivudine—hepatitis B	0.00186	0.00233	CcSEcCtD
Cyproterone acetate—Nausea—Telbivudine—hepatitis B	0.00184	0.0023	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.0018	0.00226	CcSEcCtD
Cyproterone acetate—Discomfort—Lamivudine—hepatitis B	0.00179	0.00224	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—hepatitis B	0.00179	0.0271	CbGpPWpGaD
Cyproterone acetate—Oedema—Lamivudine—hepatitis B	0.00174	0.00218	CcSEcCtD
Cyproterone acetate—Shock—Lamivudine—hepatitis B	0.00171	0.00214	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Lamivudine—hepatitis B	0.00171	0.00214	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Lamivudine—hepatitis B	0.0017	0.00213	CcSEcCtD
Cyproterone acetate—Skin disorder—Lamivudine—hepatitis B	0.00169	0.00212	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Lamivudine—hepatitis B	0.00168	0.00211	CcSEcCtD
Cyproterone acetate—Anorexia—Lamivudine—hepatitis B	0.00166	0.00208	CcSEcCtD
Cyproterone acetate—Hypotension—Lamivudine—hepatitis B	0.00163	0.00204	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00159	0.0241	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—APOBEC3G—hepatitis B	0.00158	0.0238	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Lamivudine—hepatitis B	0.00155	0.00194	CcSEcCtD
Cyproterone acetate—Dyspepsia—Lamivudine—hepatitis B	0.00153	0.00192	CcSEcCtD
Cyproterone acetate—Decreased appetite—Lamivudine—hepatitis B	0.00151	0.00189	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Lamivudine—hepatitis B	0.0015	0.00188	CcSEcCtD
Cyproterone acetate—Fatigue—Lamivudine—hepatitis B	0.0015	0.00188	CcSEcCtD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00149	0.0225	CbGpPWpGaD
Cyproterone acetate—Constipation—Lamivudine—hepatitis B	0.00149	0.00186	CcSEcCtD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00147	0.0222	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—hepatitis B	0.00145	0.0219	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Lamivudine—hepatitis B	0.00143	0.00179	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Lamivudine—hepatitis B	0.00142	0.00178	CcSEcCtD
Cyproterone acetate—Urticaria—Lamivudine—hepatitis B	0.00138	0.00173	CcSEcCtD
Cyproterone acetate—Body temperature increased—Lamivudine—hepatitis B	0.00138	0.00172	CcSEcCtD
Cyproterone acetate—Abdominal pain—Lamivudine—hepatitis B	0.00138	0.00172	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—APOBEC3G—hepatitis B	0.00136	0.0205	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Lamivudine—hepatitis B	0.00128	0.0016	CcSEcCtD
Cyproterone acetate—Asthenia—Lamivudine—hepatitis B	0.00125	0.00156	CcSEcCtD
Cyproterone acetate—Pruritus—Lamivudine—hepatitis B	0.00123	0.00154	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00121	0.0183	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Lamivudine—hepatitis B	0.00119	0.00149	CcSEcCtD
Cyproterone acetate—Dizziness—Lamivudine—hepatitis B	0.00115	0.00144	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—hepatitis B	0.00114	0.0172	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—MIF—hepatitis B	0.00113	0.017	CbGpPWpGaD
Cyproterone acetate—Vomiting—Lamivudine—hepatitis B	0.00111	0.00138	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—hepatitis B	0.0011	0.0166	CbGpPWpGaD
Cyproterone acetate—Rash—Lamivudine—hepatitis B	0.0011	0.00137	CcSEcCtD
Cyproterone acetate—Dermatitis—Lamivudine—hepatitis B	0.0011	0.00137	CcSEcCtD
Cyproterone acetate—Headache—Lamivudine—hepatitis B	0.00109	0.00136	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—AKR1B1—hepatitis B	0.00109	0.0165	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GGT2—hepatitis B	0.00106	0.016	CbGpPWpGaD
Cyproterone acetate—Nausea—Lamivudine—hepatitis B	0.00103	0.00129	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.000879	0.0133	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—hepatitis B	0.000863	0.013	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—hepatitis B	0.000843	0.0127	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CD4—hepatitis B	0.000771	0.0117	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL10—hepatitis B	0.000749	0.0113	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.00073	0.011	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—hepatitis B	0.00072	0.0109	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hepatitis B	0.0007	0.0106	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.000667	0.0101	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CDKN2A—hepatitis B	0.000665	0.01	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—HLA-A—hepatitis B	0.00066	0.00997	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2A6—hepatitis B	0.000642	0.0097	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—hepatitis B	0.000581	0.00877	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CTNNB1—hepatitis B	0.000556	0.0084	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—hepatitis B	0.000535	0.00808	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR0B2—hepatitis B	0.000523	0.0079	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL10—hepatitis B	0.00052	0.00786	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GGT1—hepatitis B	0.000502	0.00757	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN2A—hepatitis B	0.000452	0.00682	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—hepatitis B	0.000448	0.00676	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IFNG—hepatitis B	0.000441	0.00665	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000433	0.00654	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000425	0.00641	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000411	0.00621	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CTNNB1—hepatitis B	0.000411	0.00621	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—FAS—hepatitis B	0.000409	0.00618	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CDKN1A—hepatitis B	0.000402	0.00607	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PTEN—hepatitis B	0.000401	0.00605	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NR0B2—hepatitis B	0.000397	0.006	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000397	0.00599	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000395	0.00596	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL2—hepatitis B	0.000392	0.00591	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hepatitis B	0.000388	0.00586	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—CTNNB1—hepatitis B	0.000387	0.00584	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CTNNB1—hepatitis B	0.000378	0.00571	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PTEN—hepatitis B	0.000368	0.00556	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—HNF4A—hepatitis B	0.000363	0.00548	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—hepatitis B	0.000345	0.00521	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000329	0.00496	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hepatitis B	0.000325	0.00491	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—hepatitis B	0.000323	0.00488	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—hepatitis B	0.000313	0.00472	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—hepatitis B	0.000305	0.00461	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—HNF4A—hepatitis B	0.000275	0.00416	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000269	0.00407	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000263	0.00396	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000262	0.00396	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000261	0.00395	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000255	0.00384	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR0B2—hepatitis B	0.000252	0.00381	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—hepatitis B	0.000251	0.0038	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000232	0.0035	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CTNNB1—hepatitis B	0.00023	0.00348	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—hepatitis B	0.00023	0.00348	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000226	0.00341	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CDKN1A—hepatitis B	0.000225	0.0034	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000225	0.0034	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000223	0.00337	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—hepatitis B	0.000222	0.00335	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000218	0.00329	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000218	0.00329	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000216	0.00327	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—hepatitis B	0.000203	0.00306	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000199	0.00301	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000198	0.00299	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000193	0.00292	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000193	0.00291	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NR0B2—hepatitis B	0.000191	0.00289	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKR1B1—hepatitis B	0.000189	0.00286	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—hepatitis B	0.000186	0.00281	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GGT2—hepatitis B	0.000181	0.00274	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.00018	0.00272	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000179	0.00271	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HNF4A—hepatitis B	0.000175	0.00264	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—hepatitis B	0.000174	0.00262	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000168	0.00254	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—hepatitis B	0.00016	0.00241	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000154	0.00233	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—hepatitis B	0.00015	0.00227	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000148	0.00224	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—hepatitis B	0.00014	0.00212	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HNF4A—hepatitis B	0.000132	0.002	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000121	0.00183	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2A6—hepatitis B	0.00011	0.00166	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000102	0.00155	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GOT2—hepatitis B	9.94e-05	0.0015	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GOT1—hepatitis B	8.58e-05	0.0013	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GGT1—hepatitis B	8.58e-05	0.0013	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	7.82e-05	0.00118	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—hepatitis B	4.56e-05	0.000689	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTEN—hepatitis B	3.48e-05	0.000526	CbGpPWpGaD
